Noninvasive ventilation use in pediatric status asthmaticus

Area of Science:

• Pediatric Critical Care Medicine
• Respiratory Medicine
• Emergency Medicine

Background:

• Noninvasive ventilation (NIV) is sometimes used for pediatric status asthmaticus to support airways and deliver medication.
• The effectiveness and safety of NIV in pediatric asthma patients remain under investigation.
• Understanding NIV usage patterns in this population is crucial for clinical practice.

Purpose of the Study:

• To describe the usage patterns, outcomes, and safety of noninvasive ventilation (NIV) in pediatric patients with status asthmaticus.
• To identify patient characteristics and common respiratory viruses associated with NIV use.
• To assess for any major adverse events related to NIV administration.

Main Methods:

• Retrospective review of electronic medical records for pediatric patients (1-21 years) admitted to the PICU with status asthmaticus from January 2016 to December 2018.
• Exclusion of patients with tracheostomies or baseline NIV.
• Data extraction included medical history, vital signs, imaging, therapies, NIV type (BiPAP/CPAP), and adverse events.

Main Results:

• 101 admissions were analyzed; 54% received NIV, frequently initiated in the emergency department.
• Patients receiving NIV had significantly lower oxygen saturation at presentation.
• Commonly identified viruses included rhinovirus/enterovirus; no major complications like pneumothorax were observed.

Conclusions:

• Noninvasive ventilation is commonly utilized in pediatric status asthmaticus, including early initiation in the ED.
• No significant adverse events were documented, suggesting a potentially safe profile for NIV in this context.
• Further research, including randomized controlled trials, is necessary to confirm NIV's impact on treatment duration and patient outcomes.